Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

Pfizer, BioNTech in deal with Canada to supply COVID vaccine hopeful

FILE PHOTO: A sign is pictured outside Pfizer Headquarters in the Manhattan borough of New York City, New York, U.S., July 22, 2020. REUTERS/Carlo Allegri

Canada on Wednesday secured supplies of an experimental COVID-19 vaccine developed by Pfizer and German biotech firm BioNTech for delivery in 2021 if the compound wins regulatory approval.

Financial details of the agreement were not disclosed, Pfizer and BioNTech said in a joint statement, but added that the terms were based on the timing of delivery and the volume of doses.

FILE PHOTO: The headquarters of biopharmaceutical company BioNTech are seen in Mainz, Germany July 31, 2018. REUTERS/Ralph Orlowski

(Reporting by Ludwig Burger. Editing by Jane Merriman)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.